April 18, 2012
Presentation Of 1-Year IVAN And 2-Year CATT Study Results
Special session at the 2012 ARVO Annual Meeting
ARVO is pleased to host a presentation of the one-year results from the U.K.'s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study and the two-year results of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) trial.
The presentation will also live-streamed at http://prolibraries.com/arvo/registration/event. While annual meeting registration is required for the session in Fort Lauderdale, the online is event is free.
The 2012 ARVO Annual Meeting, Translational Research: Seeing the Possibilities, takes place May 6 — 10 in Fort Lauderdale, Fla. Registration information can be found at www.arvo.org/am.
On the Net: